The Importance of Gleevec Following Surgery for Gastrointestinal Stromal Cell Tumors (GIST)

June 11th, 2014 @

Surgical resection is the only treatment with the potential to cure GISTs. Unfortunately many patients develop recurrent tumors following complete tumor removal. Imatinib mesylate or Gleevec helps prevent recurrence of GIST following surgical resection.  Few studies have evaluated national practices and the results of Gleevec on survival of GIST patients. We used Surveillance Epidemiology and … Read More »

A Fool with a Tool is Still a Fool

April 22nd, 2014 @

A recent study compared Robot-assisted radical prostatectomy (RARP) to standard open prostatectomy. According to the study, patients who underwent RARP had significantly higher complications rates at 30 and 90 days, and total hospital costs in the first year after surgery were significantly higher in the RARP patients. The report in the Journal of Clinical Oncology. used … Read More »

New Hope for Patients with Advanced Melanoma

April 8th, 2014 @

Melanoma is the deadliest form of skin cancer. It accounts for less than 5 percent of skin cancer cases but it is responsible for three quarters of skin cancer deaths. When melanoma is diagnosed in its early stage, before it has spread to the lymph nodes, the five-year survival rate is about 98 percent. However, … Read More »

Avoiding Radiation Therapy for Breast Cancer

March 30th, 2014 @

I recently attended the 67th annual meeting of the Society of Surgical Oncology. The three day meeting which took place in downtown Phoenix Arizona, attracted over 1500 cancer surgeons from throughout the US and worldwide. One of the notable presentations came from Kevin Hughes M.D. from Harvard. He presented an update of a national trial … Read More »

Biology is King

March 26th, 2014 @

“Biology is King; selection of cases is Queen, and the technical details of surgical procedures are princes and princesses of the realm who frequently try to overthrow the powerful forces of the King and Queen, usually to no long-term avail, although with some temporary apparent victories.” This insight, shared by Blake Cady, MD, is certainly … Read More »


What is Surgical Oncology?

Surgical oncology is a specialty that focuses on the surgical treatment of a variety of tumors, the most common being breast cancer, colorectal cancer, pancreatic and gastric cancer, liver tumors, melanoma, and endocrine tumors. Surgical oncology requires a specialized two year training program after a general surgery residency. Currently training comes from programs approved by the Society of Surgical Oncology (SSO). Dr. Ellenhorn graduated from the prestigious SSO-certified Surgical Oncology Training Program at Memorial Sloan-Kettering Cancer Center MSKCC.org and he directed the SSO-certified Surgical Oncology Training Program at City of Hope for 10 years. mskcc.org. The American Board of Surgery (ABS) has received approval to offer a new subspecialty certificate in complex general surgical oncology. Learn more about surgical oncology »

Instructional Videos

Robotic Spleen Preserving Distal Pancreatectomy

Robotic Repair of a Femoral Hernia

Laparoscopic Resection of a Gastric GIST

Dr. Ellenhorn on the Doctor's Show

Intraoperative Radiation Therapy for Breast Cancer: Case Demonstration

Intraoperative Radiation Therapy for Breast Cancer

Laparoscopic and Robotic Total Gastrectomy for Stomach Cancer

Laparoscopic and Robotic Distal Gastrectomy for Cancer

Laparoscopic Subtotal Gastrectomy and D2 Lymphadenectomy for Cancer




Dr. Ellenhorn’s Recent Publications

2012.Oxner CR, Vora L, Yim J, Kruper L, Ellenhorn JDI. Magnetic resonance imaging-guided breast biopsy in lesions not visualized by mammogram or ultrasound. American Surgeon 2012 78:1087-1090 2012.Learn More »
2012.Arrington AK, Nelson R, Chen SL, Ellenhorn JDI, Garcia-Aguilar J, Kim J. The Evolution of Surgical Technique for Total Gastrectomy Over a 12-Year Period: A Single Institution's Experience. American Surgeon 2012 78:1054-1058 2012.Learn More »
2012. Blache CA, Manuel ER, Kaltcheva TI, Wong AN, Ellenhorn JDI, Blazar BR, Diamond DJ. Systemic Delivery of Salmonella Typhimurium Transformed with IDO shRNA Enhances Intratumoral Vector Colonization and Suppresses Tumor Growth. Cancer Res. 72:6447-6456 2012.Learn More »
2013.Aronowitz JA, Ellenhorn JDI. Adipose Stromal Vascular Fraction Isolation: A Head-to-Head Comparison of Four Commercial Cell Separation Systems. Plast Reconstr Surg. 132:932-939 2013.Learn More »
2013.Ellenhorn JDI. When it comes to the efficacy of metastasectomy, biology is king. Oncology (Williston Park). 27:1051, 2013.Learn More »